Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 1
2004 1
2005 2
2006 1
2008 1
2014 1
2015 3
2016 1
2018 3
2019 3
2020 2
2022 2
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Neurological complications of beta-thalassemia.
Nemtsas P, Arnaoutoglou M, Perifanis V, Koutsouraki E, Orologas A. Nemtsas P, et al. Among authors: orologas a. Ann Hematol. 2015 Aug;94(8):1261-5. doi: 10.1007/s00277-015-2378-z. Epub 2015 Apr 24. Ann Hematol. 2015. PMID: 25903043 Review.
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group. Vermersch P, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35190477 Free PMC article. Clinical Trial.
Multiple sclerosis registries in Europe - results of a systematic survey.
Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli O; EUReMS Consortium. Flachenecker P, et al. Among authors: orologas a. Mult Scler. 2014 Oct;20(11):1523-32. doi: 10.1177/1352458514528760. Epub 2014 Apr 28. Mult Scler. 2014. PMID: 24777278
Cognitive and brain reserve in multiple sclerosis--A cross-sectional study.
Ifantopoulou P, Artemiadis AK, Bakirtzis C, Zekiou K, Papadopoulos TS, Diakogiannis I, Hadjigeorgiou G, Grigoriadis N, Orologas A. Ifantopoulou P, et al. Among authors: orologas a. Mult Scler Relat Disord. 2019 Oct;35:128-134. doi: 10.1016/j.msard.2019.07.027. Epub 2019 Jul 29. Mult Scler Relat Disord. 2019. PMID: 31374461
A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis.
Logothetis L, Mylonas IA, Baloyannis S, Pashalidou M, Orologas A, Zafeiropoulos A, Kosta V, Theoharides TC. Logothetis L, et al. Among authors: orologas a. Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):771-8. doi: 10.1177/039463200501800421. Int J Immunopathol Pharmacol. 2005. PMID: 16388727 Free article. Clinical Trial.
22 results